Communiqués Illumina, Inc.

Actions

ILMN

US4523271090

Temps réel estimé Cboe BZX Autres places de cotation 18:51:02 10/06/2024			Varia. 5j.	Varia. 1 janv.
108,7 ^USD	-4,39 %		+5,22 %	-21,88 %

14:09	KKR : va intégrer l'indice S&P 500	AO
12:39	KKR & Co, CrowdStrike et GoDaddy rejoindront l'indice S&P 500 le 24 juin	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost	04/06	PR
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares	03/06	PR
Illumina appoints Everett Cunningham Chief Commercial Officer	03/06	PR
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO	30/05	AQ
Illumina releases 2023 Corporate Social Responsibility Report	28/05	PR
Anna Richo joins Illumina's Board of Directors	20/05	PR
Illumina To Webcast Upcoming Investor Conference	15/05	PR
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024	08/05	AQ
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL	07/05	PR
Illumina to Webcast Upcoming Investor Conference	06/05	AQ
Illumina To Webcast Upcoming Investor Conference	03/05	PR
Illumina : First Quarter 2024 Prepared Remarks	03/05	PU
Illumina: Q1 Earnings Snapshot	02/05	AQ
Illumina : 2024 Assurance Statement	23/04	PU
Illumina's planned divestment of GRAIL approved by the European Commission	15/04	AQ
Illumina's planned divestment of GRAIL approved by the European Commission	12/04	PR
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer	09/04	PR
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024	04/04	PR
GRAIL Presents New Data on Galleri and Its Methylation Platform at the Annual American Association for Cancer Research Meeting	28/03	AQ
Devyser Diagnostics AB publishes year-end report for January to December 2023	20/02	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Illumina, Inc.

Actions

ILMN

US4523271090

Communiqués

Filtres